AMBILI GEORGE: Open Payments
NPI 1407503873 · ELLICOTT CITY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 14 payments from 12 companies in 2025. Trend: 2023 $166 · 2024 $413 · 2025 $652
Food & beverage: $652
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $111 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $110 |
| Insmed, Inc. | 1 | $98 |
| Dexcom, Inc. | 1 | $67 |
| Astellas Pharma US Inc | 2 | $51 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $50 |
| Smith+Nephew, Inc. | 1 | $47 |
| Madrigal Pharmaceuticals | 1 | $40 |
| Lilly USA, LLC | 1 | $24 |
| Baxter Healthcare | 1 | $23 |
Products named: LINZESS, XIFAXAN, Arikayce, Dexcom G6 Transmitter, Veozah, NEFFY, COLLAGENASE SANTYL, REZDIFFRA.
Industry payments across MD — which companies pay providers there.
